Crossmark

Adequate antibody response to BioNTech COVID vaccine in a multiple sclerosis patient treated with siponimod

Published Online: 2021-12-14

Published Print: 2021-12

Authors

Siddiqui, Gulnaz https://orcid.org/0000-0001-8098-0763
Maloni, Heidi

Nava, Victor E.
License Information

Text and Data Mining valid from 2021-12-01

Version of Record valid from 2021-12-14
More Information

Article History

Received: 7 November 2021

Accepted: 30 November 2021

First Online: 14 December 2021

Declarations

:

: Not applicable.

: Not applicable.

: The authors confirm that they have no competing interests.

Document is current